The app.epignostix.com platform offers a user-friendly implementation of the Heidelberg Epignostix CNS Tumor Methylation Classifier and Sarcoma Methylation Classifier, which are freely accessible for academic research and scientific use. We invite research groups to contribute and validate our solutions, striving for continuous improvement in routine patient care and cancer research. We offer global access to cloud-based API services (AIaaS) for state-of-the-art diagnostics tools (Contact: info@epignostix.com)

More information is provided on our website.